July 12th 2010 – Ethypharm announces the commercial launch in the US of a new product using its Flashtab® technology. Tramadol Flashtab® is available since end of May, 2010. This new commercial launch confirms Ethypharm’s strong commitment to increase its presence on the North American market.Ethypharm pursues its development in North America
After Antara® 130mg – an innovative form of Fenofibrate – Ethypharm’s introduction of Tramadol Flashtab®, its second specialty product in the United States, demonstrates its determination to grow in North America. Ethypharm’s mid terms objective is to double its US sales and bring them from actual 12% to 25% of its total sales by 2014. Five products developed specifically for the American market are under active regulatory review at the agency and are scheduled for commercial launch from 2011 thru 2014...
[...)
...Ethypharm is one of the leading pharmaceutical companies dedicated to the development of innovative medicines. Its patented technologies offer multiple benefits for patients by improving efficacy, administration, compliance, and reducing side-effects.
Ethypharm provides its clients with solutions for the life cycle management of their drugs. The company has one of the broadest portfolios of technologies to become the worldwide privileged partner of pharmaceutical companies. Ethypharm offers customized solutions for the development of the medicines of the future... Ethypharm's Press Release - communiqué de presse d'Ethypharm -
